Improving depression and enhancing resilience in family dementia caregivers: A pilot randomized placebo-controlled trial of escitalopram

American Journal of Geriatric Psychiatry

Volumn 18, Issue 2, 2010, Pages 154-162

  Lavretsky, Helen ^a   Siddarth, Prabha ^b   Irwin, Michael R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Dementia caregiver; Depression; Escitalopram; Quality of life; Resilience; Stress

Indexed keywords

ESCITALOPRAM; PLACEBO;

ADULT; AGED; ALZHEIMER DISEASE; ANXIETY; ARTICLE; BEHAVIOR DISORDER; CAREGIVER; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISEASE SEVERITY; DISTRESS SYNDROME; FAMILY COUNSELING; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REMISSION; STRESS;

EID: 75149152945     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3181beab1e     Document Type: Article

References (51)

1. Schulz R, Beach SR: Caregiving as a risk factor for mortality: the Caregiver Health Effects Study. JAMA 1999; 282:2215-2219
2. Schulz R, Martire LM: Family caregiving of persons with dementia: prevalence, health effects, and support strategies. Am J Geri-atr Psychiatry 2004; 12:240-249
3. Ory MG, Hoffman RR III, Yee JL, et al: Prevalence and impact of caregiving: a detailed comparison between dementia and nonde-mentia caregivers. Gerontologist 1999; 39:177-185
4. Schulz R, O'Brien AT, Czaja S, et al: Dementia caregiver intervention research: in search of clinical significance. Gerontologist 2002; 42:589-602
5. Vitaliano PP, Zhang J, Scanlan JM: Is caregiving hazardous to one's physical health? A meta-analysis. Psychol Bull 2003; 129:946-972
6. Wagner DL: Comparative Analysis of Caregiver Data for Caregiv-ers to the Elderly 1987 and 1997. Bethesda, MD, National Alliance for Caregiving, 1997
7. Lavretsky H: Stress and depression in informal dementia caregivers. Health Aging 2005; 1:117-133
8. McEwen BS: Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann N Y Acad Sci 2004; 1032:1-7
9. McEwen BS, Stellar E: Stress and the individual. Mechanisms leading to disease. Arch Intern Med 1993; 153:2093-2101
10. Damjanovic AK, Yang Y, Glaser R, et al: Accelerated telomere erosion is associated with a declining immune function of care-givers of Alzheimer's disease patients. J Immunol 2007; 179: 4249-4254
11. Kiecolt-Glaser JK, Glaser R, Gravenstein S, et al: Chronic stress alters the immune response to influenza virus vaccine in older adults. Proc Natl Acad Sci USA 1996; 93:3043-3047
12. Lavretsky H, Ballmaier M, Pham D, et al: Neuroanatomical characteristics of geriatric apathy and depression: a magnetic resonance imaging study. Am J Geriatr Psychiatry 2007; 15:386-394
13. Lavretsky H, Roybal DJ, Ballmaier M, et al: Antidepressant exposure may protect against decrement in frontal gray matter volumes in geriatric depression. J Clin Psychiatry 2005; 66:964-967
14. Mills PJ, Adler KA, Dimsdale JE, et al: Vulnerable caregivers of Alzheimer disease patients have a deficit in beta 2-adrenergic receptor sensitivity and density. Am J Geriatr Psychiatry 2004; 12:281-286
15. Mills PJ, Yu H, Ziegler MG, et al: Vulnerable caregivers of patients with Alzheimer's disease have a deficit in circulating CD62L-T lymphocytes. Psychosom Med 1999; 61:168-174
16. Zarit SH: Diagnosis and management of caregiver burden in dementia. Handb Clin Neurol 2008; 89:101-106
17. Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1:385-401
18. Cipriani A, La. Ferla T, Furukawa TA, et al: Sertraline versus other antidepressive agents for depression. Cochrane Database Syst Rev 2009; CD006117
19. Cipriani A, Santilli C, Furukawa TA, et al: Escitalopram versus other antidepressive agents for depression. Cochrane Database Syst Rev 2009; CD006532
20. Moore N, Verdoux H, Fantino B: Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. Int Clin Psychopharmacol 2005; 20:131-137
21. Rampello L, Alvano A, Raffaele R, et al: New possibilities of treatment for panic attacks in elderly patients: escitalopram versus citalopram. J Clin Psychopharmacol 2006; 26:67-70
22. Lader M, Andersen HF, Baekdal T: The effect of escitalopram on sleep problems in depressed patients. Hum Psychopharmacol 2005; 20:349-354
23. Stein DJ, Andersen HF, Goodman WK: Escitalopram for the treatment of GAD: efficacy across different subgroups and outcomes. Ann Clin Psychiatry 2005; 17:71-75
24. First MB, Gibbon M, Spitzer RL, et al: User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders-Research Version-(SCID-I), Version 2.0, Arlington, VA: American Psychiatric Publishing, Inc.; 1996
25. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50-55
26. Connor KM, Davidson JR: Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety 2003; 18:76-82
27. Lamond AJ, Depp CA, Allison M, et al: Measurement and predictors of resilience among community-dwelling older women. J Psy-chiatr Res 2008; 43:148-154
28. Teri L, Truax P, Logsdon R, et al: Assessment of behavioral problems in dementia: the revised memory and behavior problems checklist. Psychol Aging 1992; 7:622-631
29. Lingjaerde O, Ahlfors UG, Bech P, et al: The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987; 334:1-100
30. Zarit SH, Reever KE, Bach-Peterson J: Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 1980; 20:649-655
31. American Heart Association: Stroke Risk Factor Prediction Chart. Dallas, TX, American Heart Association, 1990
32. Miller MD, Paradis CF, Houck PR, et al: Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992; 41:237-248
33. Fuh JL, Liu CY, Wang SJ, et al: Revised memory and behavior problems checklist in Taiwanese patients with Alzheimer's disease. Int Psychogeriatr 1999; 11:181-189
34. Roth DL, Burgio LD, Gitlin LN, et al: Psychometric analysis of the Revised Memory and Behavior Problems Checklist: factor structure of occurrence and reaction ratings. Psychol Aging 2003; 18:906-915
35. Schulz R, Martire LM, Klinger JN: Evidence-based caregiver interventions in geriatric psychiatry. Psychiatr Clin North Am 2005; 28:1007-1038, x
36. Marriott A, Donaldson C, Tarrier N, et al: Effectiveness of cognitive-behavioural family intervention in reducing the burden of care in carers of patients with Alzheimer's disease. Br J Psychiatry 2000; 176:557-562
37. Mittelman MS, Ferris SH, Shulman E, et al: A comprehensive support program: effect on depression in spouse-caregivers of AD patients. Gerontologist 1995; 35:792-802
38. Mittelman MS, Roth DL, Coon DW, et al: Sustained benefit of supportive intervention for depressive symptoms in caregivers of patients with Alzheimer's disease. Am J Psychiatry 2004; 161: 850-856
39. Sorensen S, Pinquart M, Duberstein P: How effective are interventions with caregivers? An updated meta-analysis. Gerontolo-gist 2002; 42:356-372
40. Hosaka T, Sugiyama Y: Structured intervention in family caregivers of the demented elderly and changes in their immune function. Psychiatry Clin Neurosci 2003; 57:147-151
41. Vedhara K, Miles J, Bennett P, et al: An investigation into the relationship between salivary cortisol, stress, anxiety and depression. Biol Psychol 2003; 62:89-96
42. Coon DW, Thompson L, Steffen A, et al: Anger and depression management: psychoeducational skill training interventions for women caregivers of a relative with dementia. Gerontologist 2003; 43:678-689
43. Eisdorfer C, Czaja SJ, Loewenstein DA, et al: The effect of a family therapy and technology-based intervention on caregiver depression. Gerontologist 2003; 43:521-531
44. Gitlin LN, Belle SH, Burgio LD, et al: Effect of multicomponent interventions on caregiver burden and depression: the REACH multisite initiative at 6-month follow-up. Psychol Aging 2003; 18:361-374
45. Wisniewski SR, Belle SH, Coon DW, et al: The Resources for Enhancing Alzheimer's Caregiver Health (REACH): project design and baseline characteristics. Psychol Aging 2003; 18:375-384
46. Levesque L, Gendron C, Vezina J, et al: The process of a group intervention for caregivers of demented persons living at home conceptual framework, components, and characteristics. Aging Ment Health 2002; 6:239-247
47. Pinquart M, Sorensen S: Helping caregivers of persons with dementia: which interventions work and how large are their effects? Int Psychogeriatr 2006; 18:577-595
48. Kozel FA, Trivedi MH, Wisniewski SR, et al: Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report. Am J Geriatr Psychiatry 2008; 16:58-64
49. Roose SP, Sackeim HA, Krishnan KR, et al: Antidepressant phar-macotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am J Psychiatry 2004; 161: 2050-2059
50. Roose SP, Schatzberg AF: The efficacy of antidepressants in the treatment of late-life depression. J Clin Psychopharmacol 2005; 25:S1-S7
51. Schatzberg A, Roose S: A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression. Am J Geriatr Psychiatry 2006; 14:361-370